Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is an ANOVA?01:16

What is an ANOVA?

8.0K
The Analysis of Variance or ANOVA is a statistical test developed by Ronald Fisher in 1918. It is performed on three or more samples to check for equality between their means.
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples should be randomly and...
8.0K
Aromatic Hydrocarbon Anions: Structural Overview01:18

Aromatic Hydrocarbon Anions: Structural Overview

2.8K
Neutral hydrocarbons like cyclopentadiene with an odd number of carbon atoms and one intervening CH2 group in the ring are not aromatic. Cyclopentadiene with 4 π electrons does not satisfy the 4n + 2 π electron rule. Additionally, the intervening CH2 group is sp3 hybridized and lacks a vacant p orbital, thereby interrupting the overlap of p orbitals in a continuous manner and preventing the delocalization of π electrons throughout the ring.
Due to the absence of continuous...
2.8K
What is ANOVA?01:13

What is ANOVA?

2.0K
The Analysis of Variance or ANOVA is a statistical test developed by Ronald Fisher in 1918. It is performed on three or more samples to check for equality between their means.
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples be randomly and independently...
2.0K
Anastomoses01:19

Anastomoses

907
In human anatomy, anastomosis refers to a connection or opening between two things, particularly between blood vessels or other tubular structures. The term is derived from the Greek term 'anastomosis,' which means 'outlet' or 'opening.' This natural network of connections plays a critical role in the survival and functionality of the human body.
Anastomoses can be formed at arterial, venous, and lymphatic vessels.
Arterial Anastomosis: These occur between arteries. They...
907
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

421
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
421
Statistical Methods to Analyze Parametric Data: ANOVA01:12

Statistical Methods to Analyze Parametric Data: ANOVA

454
Analysis of Variance, or ANOVA, is a powerful statistical technique used to analyze parametric data, primarily in research and experimental studies. It's designed to compare the means of two or more groups, assisting researchers in identifying any significant differences between these group means. There are two main types of ANOVA based on the complexity of the analysis: one-way and two-way.
One-way ANOVA is applied when a single independent variable or factor is scrutinized. It compares...
454

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Larrea ameghinoi</i> Speg. (Zygophyllaceae) "Jarilla Rastrera": UHPLC-ESI-QTOF-MS Analysis, Antioxidant, Antimicrobial Properties, and Inhibition of Enzymes of Interest to Human Health.

Antioxidants (Basel, Switzerland)·2026
Same author

Neonatal nurse practitioners' perspective on fatigue, safety, and collaboration during 24-hour shifts in the neonatal intensive care unit.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Feasibility and Measurement of Bedside Milk Expression in the NICU: A Mixed Methods Study.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses·2025
Same author

Integrating Biological, Behavioral, and Economic Factors in the Practice and Study of Early, Unplanned Lactation Cessation.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2025
Same author

Chronic IL-1-Exposed LNCaP Cells Evolve High Basal p62-KEAP1 Complex Accumulation and NRF2/KEAP1-Dependent and -Independent Hypersensitive Nutrient Deprivation Response.

Cells·2025
Same author

Biological activities of <i>Usnea lethariiformis</i> lichen extracts and UHPLC-ESI-QTOF-MS analysis of their secondary metabolites.

Frontiers in pharmacology·2025

Related Experiment Video

Updated: Jul 27, 2025

High-Speed Magnetic Tweezers for Nanomechanical Measurements on Force-Sensitive Elements
08:50

High-Speed Magnetic Tweezers for Nanomechanical Measurements on Force-Sensitive Elements

Published on: May 12, 2023

2.2K

An

Jessica Gómez1, Laura Artigas1, Raquel Valls1

  • 1Anaxomics Biotech SL, Barcelona, Spain.

Molecular Genetics and Metabolism Reports
|June 5, 2023
PubMed
Summary

Systems biology modeling identified 16 potential biomarkers for early tissue damage in Metachromatic leukodystrophy (MLD). These biomarkers, including pro-neuregulin-1, show promise for distinguishing MLD patients from controls and subtypes.

Keywords:
BiomarkerDemyelinationIn silicoMetachromatic leukodystrophyModelingSystems biology

More Related Videos

Enhancement Method of Surface Acoustic Wave-Atomizer Efficiency for Olfactory Display
08:06

Enhancement Method of Surface Acoustic Wave-Atomizer Efficiency for Olfactory Display

Published on: November 14, 2018

8.1K
Aortic Ring Assay
09:12

Aortic Ring Assay

Published on: November 24, 2009

31.3K

Related Experiment Videos

Last Updated: Jul 27, 2025

High-Speed Magnetic Tweezers for Nanomechanical Measurements on Force-Sensitive Elements
08:50

High-Speed Magnetic Tweezers for Nanomechanical Measurements on Force-Sensitive Elements

Published on: May 12, 2023

2.2K
Enhancement Method of Surface Acoustic Wave-Atomizer Efficiency for Olfactory Display
08:06

Enhancement Method of Surface Acoustic Wave-Atomizer Efficiency for Olfactory Display

Published on: November 14, 2018

8.1K
Aortic Ring Assay
09:12

Aortic Ring Assay

Published on: November 24, 2009

31.3K

Area of Science:

  • Biochemistry
  • Genetics
  • Systems Biology

Background:

  • Metachromatic leukodystrophy (MLD) is a rare, autosomal recessive lysosomal storage disease.
  • Deficient arylsulfatase A activity leads to sulfatide accumulation, causing progressive demyelination and neurodegeneration in the central and peripheral nervous systems.
  • Genotype-phenotype correlations in MLD remain incompletely understood, necessitating biomarkers for early damage detection.

Purpose of the Study:

  • To identify potential biomarkers for early tissue damage in Metachromatic leukodystrophy (MLD) using a systems biology modeling approach.
  • To evaluate proteins involved in MLD pathophysiology across different disease stages.
  • To prioritize biomarkers capable of differentiating disease states and subtypes.

Main Methods:

  • Literature review to characterize MLD pathophysiology and identify relevant proteins.
  • Development of three mathematical models simulating early, pre-demyelination, and demyelination stages of MLD.
  • Data mining and filtering of 3457 proteins to identify potential biomarkers distinguishing disease models.

Main Results:

  • Sixteen potential biomarkers were identified, related to mitochondrial dysfunction, remyelination, and neurodegeneration.
  • Validation in T lymphocyte gene expression data confirmed biomarker combinations distinguishing MLD patients from controls.
  • Pro-neuregulin-1 and casein kinase II subunit alpha showed promise as differential markers for MLD and its subtypes.

Conclusions:

  • Mathematical modeling effectively identified sensitive biomarker candidates for early MLD tissue damage.
  • The identified panel of biomarkers warrants experimental validation for clinical application.
  • This approach highlights the utility of systems biology in discovering diagnostic and prognostic markers for rare diseases like MLD.